Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis
Journal of Alzheimer’s Disease · 21.11.2023 · 96 (3) · 927-945
DOI: 10.3233/jad-230593 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 30.10.2023. Verfasst von Jiahui Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Thiazolidinediones, Alzheimer Disease, Ferroptosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the main cause of dementia in older age. The prevalence of AD is growing worldwide, causing a tremendous burden to societies and families. Due to the complexity of its pathogenesis, the current treatment of AD is not satisfactory, and drugs acting on a single target may not prevent AD progression. This review summarizes the multi-target pharmacological effects of thiazolidinediones (TZDs) on AD. TZDs act as peroxisome proliferator-activated receptor gamma (PPAR γ) agonists and long-chain acyl-CoA synthetase family member 4 (ACSL4) inhibitors. TZDs ameliorated neuroinflammation and ferroptosis in preclinical models of AD. Here, we discussed recent findings from clinical trials of pioglitazone in the treatment of AD, ischemic stroke, and atherosclerosis. We also dissected the major limitations in the clinical application of pioglitazone and explained the potential benefit of pioglitazone in AD. We recommend the use of pioglitazone to prevent cognitive decline and lower AD risk in a specific group of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Zitieren
APA
Yang, J., Shi, X., Wang, Y., Ma, M., Liu, H., Wang, J., & Xu, Z. (2023). Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis. Journal of Alzheimer’s Disease, 96(3), 927-945. https://doi.org/10.3233/jad-230593
Vancouver
Yang J, Shi X, Wang Y, Ma M, Liu H, Wang J, et al. Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis. Journal of Alzheimer’s Disease. 2023;96(3):927-945. doi:10.3233/jad-230593
BibTeX
@article{Yang2023,
author = {Yang, Jiahui and Shi, Xiaohua and Wang, Yingying and Ma, Ming and Liu, Hongyu and Wang, Jiaoqi and Xu, Zhongxin},
title = {Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
volume = {96},
number = {3},
pages = {927--945},
doi = {10.3233/jad-230593}
}
EUVIMED